@CanisPundit I worked for a U.S.-based pharma CRO, and WuXi was a huge competitor of ours. A lot of our biotech customers used them because they were so inexpensive relative to domestic CROs. This article suggests that there's a hidden cost to working with WuXi: the potential theft of your company's IP.
@dfohio exactly! Additionally, for global trials and navigating approval by China's National Medical Products Administration sponsors probably assumed the WuXi relationship would be a competitive advantage.
CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.